CJC-1295 NO DAC 10mg + IPA 10mg
This research blend contains two peptides involved in the growth hormone axis, CJC-1295 NO DAC 10mg + IPA 10mg, combined in a single lyophilized vial. It pairs a modified growth hormone-releasing hormone (GHRH) 1-29 analogue with a selective growth hormone secretagogue receptor (GHS-R) agonist. This combination enables simultaneous study of GHRH and ghrelin/GHS pathway activity.
CJC-1295 NO DAC 10mg + IPA 10mg
Sale!7%
This research blend contains two peptides involved in the growth hormone axis, CJC-1295 NO DAC 10mg + IPA 10mg, combined in a single lyophilized vial. It pairs a modified growth hormone-releasing hormone (GHRH) 1-29 analogue with a selective growth hormone secretagogue receptor (GHS-R) agonist. This combination enables simultaneous study of GHRH and ghrelin/GHS pathway activity.
$144.00
Buy more, save more!
-
Save 2%
Buy 3, get $2.50 off each
$144.00Per item: $141.50Total price: $424.50 -
Save 3%
Buy 5, get $3.75 off each
$144.00Per item: $140.25Total price: $701.25 -
Save 5%
Buy 10, get $7.50 off each
$144.00Per item: $136.50Total price: $1,365.00
$155.00$144.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
The CJC-1295 NO DAC 10mg + IPA 10mg blend is a high-purity, research-grade peptide formulation intended exclusively for controlled laboratory investigation of the somatotropic axis and growth hormone regulation.
CJC-1295 (NO DAC) is a synthetic Growth Hormone-Releasing Hormone analogue and a shorter-acting version of CJC-1295 that does not include the Drug Affinity Complex (DAC). It allows for more precise temporal assessment of growth hormone release in experimental models.
Ipamorelin is a synthetic growth hormone secretagogue designed to selectively stimulate growth hormone release in research models with minimal interaction with other endocrine pathways.
Research focus areas:
- Hypertrophic Signalling: Examine the regulation of IGF-1 expression and its involvement in tissue repair, muscle protein synthesis, and bone density maintenance.
- Metabolic Efficiency: Effects on basal metabolic rate, fat oxidation, and nitrogen balance in experimental models.
- Selective Potency: Ipamorelin is noted for its receptor selectivity, with research indicating minimal influence on prolactin, cortisol, or ACTH, making it useful for studying isolated growth hormone signalling pathways.
- Recovery and Sleep Architecture: Assess how pulsatile growth hormone release may relate to circadian rhythms and deep sleep recovery processes.
| Strength Variation |
|---|
There are no reviews yet.